🚀 Sign up Free for Public Company Valuation & Insights!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free Video Highlights
Becton Dickinson and Company
-6.42%
Healthcare & biotech / Medical equipment
At a Glance | Core Facts | Company Due Diligence: | Industry Due Diligence: | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | Web1. Competition: BD faces strong competition from numerous companies, such as Johnson & Johnson, Roche, and Siemens Healthineers, in developing and selling medical devices and laboratory instruments.
2. Regulatory Risks: As a healthcare company, BD is subject to stringent regulations, such as the US Food and Drug Administration, which are designed to protect the public health and safety of patients.
3. Geopolitical Risk: BD operates in over 100 countries, which subjects it to the risk of disruptions from political, economic, and social changes and uncertainties.
4. Unfavorable Economic Conditions: An economic downturn could negatively affect the demand for BD’s products and services, potentially leading to a decrease in sales and a decrease in earnings.
5. Foreign Exchange Risk: Currency exchange rate fluctuations could affect the company’s profits and results of operations depending on changes in exchange rates.
Wait! There's more — sign up for free or log in